Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies conducted since 2006 by EPHI and others have shown a high efficacy of AL against P. falciparum, confirming the drug remains well-tolerated and effective for the intended use in Ethiopia [4, 5, 8–10, 15, 19, 34, 35].”
In the citing paper
“With the exception of data from a location in Arbaminch in 2008, where efficacy was reported to be 92.5% (Personal communication, Moges Kassa), AL efficacy remained greater than 95% against uncomplicated P. falciparum throughout the country since the beginning of its use in 2004 [6–10].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Ebstie, Y. A., Zeynudin, A., Belachew, T., Desalegn, Z., & Suleman, S. (2015) · Malaria Journal · doi:10.1186/s12936-015-0744-x · Cited by 24
Research works printed but not linked: 52
- U Darymple, 2015, Malaria mapping: understanding the global endemicity of falciparum and vivax malaria, BMC Medicine, 13, 140, 10.1186/s12916-015-0372-x · DOI · Paper page
- J Hemingway, 2016, Tools and strategies for malaria control and elimination: What do we need to achieve a grand convergence in malaria?, PLoS Biol, 14, e1002380, 10.1371/journal.pbio.1002380 · DOI · Paper page
- U Fillinger, 2011, Larval source management for malaria control in Africa; myths and reality, Malar J, 10, 353, 10.1186/1475-2875-10-353 · DOI · Paper page
- U Darymple, 2015, Malaria mapping: understanding the global endemicity of falciparum and vivax malaria, BMC Medicine, 13, 140, 10.1186/s12916-015-0372-x · DOI · Paper page
- F Nosten, 2007, Artemisinin-based combination treatment of falciparum malaria, Am J Trop Med Hyg, 77, 181, 10.4269/ajtmh.2007.77.181 · DOI · Paper page
- RN Price, 1996, Effects of artemisinin derivatives on malaria transmissibility, Lancet, 347, 1654, 10.1016/S0140-6736(96)91488-9 · DOI · Paper page
- S Pukrittayakamee, 2004, Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria, Antimicrob Agents Chemother, 48, 1329, 10.1128/AAC.48.4.1329-1334.2004 · DOI
- K Chotivanich, 2006, Transmission-blocking activities of quinine, primaquine, and artesunate, Antimicrob Agents Chemother, 50, 1927, 10.1128/AAC.01472-05 · DOI
- LC Okell, 2008, Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials, Malar J, 7, 125, 10.1186/1475-2875-7-125 · DOI · Paper page
- FMoH: Malaria diagnosis and treatment guidelines for health workers in Ethiopia: 2nd Edition. Ministry of Health, Addis Ababa, Ethiopia; 2004.
- C Wongsrichanalai, 2013, Fighting drug-resistant Plasmodium falciparum, Clin Microbiol Infect, 19, 908, 10.1111/1469-0691.12316 · DOI
- SM Taylor, 2014, Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study, J Infect Dis, 211, 680, 10.1093/infdis/jiu467 · DOI · Paper page
- E Kamau, 2014, K13-Propeller polymorphisms in Plasmodium falciparum parasites from Sub-Saharan Africa, J Infect Dis, 211, 1352
- A Assefa, 2010, Therapeutic efficacy of Artemether/Lumefantrine (Coartem®) against Plasmodium falciparum in Kersa, Southwest Ethiopia, Parasit Vectors, 3, 10.1186/1756-3305-3-1 · DOI · Paper page
- G Getnet, 2015, Therapeutic efficacy of artemether-Lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Enfraze, north-west Ethiopia, Malar J, 14, 258, 10.1186/s12936-015-0775-3 · DOI
- T Kefyalew, 2009, efficacy of Six-dose regimen of artemether-Lumefantrine for the treatment of uncomplicated falciparum malaria, three years after its introduction into Ethiopia, Parasite, 16, 129, 10.1051/parasite/2009162129 · DOI
- A Wezam, 1994, Malaria survey at Humera, northwestern Ethiopia, Ethiop Med J, 32, 41
- T Seboxa, 1997, Epidemiological features of severe paediatric malaria in north western Ethiopia, East Afr Med J, 74, 780
- T Mengesha, 2000, The epidemiology of malaria in Humera, Northwest Ethiopia, Ethiop J Health Sci, 10, 137
- Giden D: Compiled body of works in field epidemiology. MPH Thesis. Ethiopian Field Epidemiology Training Program (EFETP), College of Health Sciences, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia; 2015.
- J Hwang, 2011, In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia, Malar J, 10, 209, 10.1186/1475-2875-10-209 · doi:10.1186/1475-2875-10-209
- D Jima, 2005, Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia, East Afr Med J, 82, 387
- G Kinfu, 2012, Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Northern Ethiopia, Malar Res Treat, 2012, 548710
- SM Kebede, 2015, Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia, Malar J, 14, 317, 10.1186/s12936-015-0826-9 · DOI
- F Wudneh, 2016, Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, northwestern Ethiopia, Therapeutics and Clinical Risk Management, 12, 1293, 10.2147/TCRM.S113603 · DOI · Paper page
- D Nega, 2016, Therapeutic efficacy of artemether-lumefantrine in treating uncomplicated P. falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study, PLoS ONE, 11, e0154618, 10.1371/journal.pone.0154618 · DOI · Paper page
- NA Anthony, 2013, Possible artemisinin-based combination therapy-resistant malaria in Nigeria, Rev Soc Bras Med Trop, 46, 525, 10.1590/0037-8682-0098-2013 · doi:10.1590/0037-8682-0098-2013
- A Djimde, 2009, Understanding the pharmacokinetics of Coartem®, Malar J, 8, S4, 10.1186/1475-2875-8-S1-S4 · DOI
- IB Muller, 2010, Antimalarial drugs: modes of action and mechanisms of parasite resistance, Future Microbiol, 5, 1857, 10.2217/fmb.10.136 · DOI
- H Noedl, 2010, Artemisinin resistance in Cambodia; a clinical trial designed to address an emerging problem in Southeast Asia, Clin Infect Dis, 51, 2010, 10.1086/657120 · DOI · Paper page
- Adeel AA, Elnour FAA, Elmardi KA, Abd-Elmajid BM, Elhelo MM, Ali MS, et al.: High efficacy of artemether-lumefantrine and declining efficacy of artesunate +sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010–2015): evidence from in vivo and molecular marker studies. Malar J 2016, 15:285. · DOI
- AA Adeel, 2015, High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen, Malar J, 14, 449, 10.1186/s12936-015-0970-2 · doi:10.1186/s12936-015-0970-2
- M Warsame, 2017, Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy, TMIH, 00
- BS Sirima, 2016, Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial, Lancet Infect Dis, 16, 1123, 10.1016/S1473-3099(16)30020-2 · DOI
- Y Mizuno, 2009, First case of treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malaria, Jpn J Infect Dis, 62, 139, 10.7883/yoken.JJID.2009.139 · DOI · Paper page
- EC Repetto, 2011, Possible clinical failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria, Mediterr J Hematol Infect Dis, 3, e2011041, 10.4084/mjhid.2011.041 · doi:10.4084/mjhid.2011.041
- A Färnert, 2012, The present report describes artemether-lumefantrine treatment failure in a traveller with P, Malar J, 11, 176
- F Gobbi, 2016, Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveler coming from Ethiopia, Malar J, 15, 525, 10.1186/s12936-016-1572-3 · DOI · Paper page
- J Pfeil, 2015, An economic evaluation of the posttreatment prophylactic effect of dihydroartemisinin-piperaquine versus artemether-lumefantrine for first-line treatment of Plasmodium falciparum malaria across different transmission settings in Africa, Am J Trop Med Hyg, 93, 961, 10.4269/ajtmh.15-0162 · doi:10.4269/ajtmh.15-0162
- Lu F, Culleton R, Zhang M, Ramaprasad A, Seidlein L, Zhou H, et al.: Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa. A letter published on February 22, 2017 at NEJM.org. · DOI · Paper page
- J Hwang, 2011, In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia, Malar J, 10, 209, 10.1186/1475-2875-10-209 · doi:10.1186/1475-2875-10-209
- B Ngasala, 2014, Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study, J Infect Dis, 211, 680
- A Shayo, 2014, Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaris in Northeastern Tanzania, Malar J, 13, 376, 10.1186/1475-2875-13-376 · doi:10.1186/1475-2875-13-376
- AM Gray, 2015, Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis, Malar J, 14, 349, 10.1186/s12936-015-0881-2 · DOI
- K Rehman, 2014, Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence, Intern J Infect Dis, 29, 268, 10.1016/j.ijid.2014.09.007 · DOI · Paper page
- Lemma M: Assessment of therapeutic efficacy of coartem® in patients with uncomplicated Plasmodium falciparum in Halaba Special Woreda, southern Ethiopia. MSc Thesis. Department of Microbial, Cellular and Molecular Biology, Addis Ababa University, Addis Ababa, Ethiopia, Addis Ababa University, Addis Ababa, Ethiopia; 2012.
- Hamde F: Monitoring the efficacy of coartem® for uncomplicated falciparum malaria in Selekleka town, Tigray Region, Northern Ethiopia. MSc thesis, Department of Microbial, Cellular and Molecular Biology, Addis Ababa University, Addis Ababa, Ethiopia; 2011.
- EB Ngasala, 2011, Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial, CID, 52, 873, 10.1093/cid/cir066 · DOI
- G Dorsey, 2007, Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial, JAMA, 297, 2210, 10.1001/jama.297.20.2210 · DOI · Paper page
- IM Hastings, 2002, The evolution of drug-resistant malaria: the role of drug elimination half-life, Philos Trans R Soc Lond B Biol Sci, 357, 505, 10.1098/rstb.2001.1036 · DOI · Paper page
- AM Nzila, 2000, Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting anti-folate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum, J Infect Dis, 181, 2023, 10.1086/315520 · DOI
- NJ White, 2008, How antimalarial drug resistance affects post-treatment prophylaxis, Malar J, 7
Cited by
Assefa, A., Mohammed, H., Anand, A., Abera, A., Sime, H., Minta, A. A., Tadesse, M., Tadesse, Y., Girma, S., Bekele, W., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04350-z · Cited by 20
Self-citation
Metadata
- Authors
- Teklemariam, M., Assefa, A., Kassa, M., Mohammed, H., & Mamo, H.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-04-26
- Volume
- 12
- Issue
- 4
- Pages
- e0176004
- ISSN
- 1932-6203
- Cited by
- 36
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.